Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

CORRECTION: Fortress Biotech Q2 Adj. EPS $(0.46) Misses $(0.36) Estimate, Sales $16.413M Beat $14.534M Estimate

Author: Benzinga Newsdesk | August 14, 2025 05:21pm
Fortress Biotech (NASDAQ:FBIO) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of $(0.36) by 27.78 percent. This is a 36.99 percent increase over losses of $(0.73) per share from the same period last year. The company reported quarterly sales of $16.413 million which beat the analyst consensus estimate of $14.534 million by 12.93 percent. This is a 10.18 percent increase over sales of $14.896 million the same period last year.

Posted In: FBIO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist